Linden Advisors’s CERo Therapeutics CERO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16	Closed	-$325K	–	586
2022 Q3	$325K	Sell	16 -234	-94%	-$4.75M	﹤0.01%	449
2022 Q2	$5.02M	Hold	250	–	–	0.05%	232
2022 Q1	$5M	Buy	+250	New	+$5M	0.03%	325